These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6521962)

  • 1. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
    Perry EK; Perry RH; Candy JM; Fairbairn AF; Blessed G; Dick DJ; Tomlinson BE
    Neurosci Lett; 1984 Oct; 51(3):353-7. PubMed ID: 6521962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    Cheng AV; Ferrier IN; Morris CM; Jabeen S; Sahgal A; McKeith IG; Edwardson JA; Perry RH; Perry EK
    J Neurol Sci; 1991 Nov; 106(1):50-5. PubMed ID: 1779239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminergic systems in Alzheimer's disease and Parkinson's disease.
    D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
    Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
    Aubert I; Araujo DM; Cécyre D; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1992 Feb; 58(2):529-41. PubMed ID: 1729398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
    Candy JM; Perry RH; Perry EK; Irving D; Blessed G; Fairbairn AF; Tomlinson BE
    J Neurol Sci; 1983 May; 59(2):277-89. PubMed ID: 6854353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ; Martino AM; Marcus KA; Zweig RM; Singer HS; Price DL; Kellar KJ
    Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
    Araujo DM; Lapchak PA
    Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
    Ruberg M; Mayo W; Brice A; Duyckaerts C; Hauw JJ; Simon H; LeMoal M; Agid Y
    Neuroscience; 1990; 35(2):327-33. PubMed ID: 2166243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
    Perry EK; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson JA; Ince P; Blessed G; Irving D
    Ann N Y Acad Sci; 1991; 640():197-202. PubMed ID: 1723256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor changes in dementia of the Alzheimer type.
    Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Bloom SR; Corsellis JA
    J Neurochem; 1984 Dec; 43(6):1574-81. PubMed ID: 6208336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
    Kerwin JM; Morris CM; Perry RH; Perry EK
    Neurosci Lett; 1992 Aug; 143(1-2):101-4. PubMed ID: 1436650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
    Perry EK; Perry RH; Smith CJ; Dick DJ; Candy JM; Edwardson JA; Fairbairn A; Blessed G
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):806-9. PubMed ID: 2956364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
    Cross AJ; Slater P; Simpson M; Royston C; Deakin JF; Perry RH; Perry EK
    Neurosci Lett; 1987 Aug; 79(1-2):213-7. PubMed ID: 2823192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
    Whitehouse PJ; Martino AM; Wagster MV; Price DL; Mayeux R; Atack JR; Kellar KJ
    Neurology; 1988 May; 38(5):720-3. PubMed ID: 3362368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.